Viewing StudyNCT04109300



Ignite Creation Date: 2024-05-06 @ 1:43 PM
Last Modification Date: 2024-10-26 @ 1:19 PM
Study NCT ID: NCT04109300
Status: UNKNOWN
Last Update Posted: 2019-09-30
First Post: 2019-09-27

Brief Title: Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease
Sponsor: Western University Canada
Organization: Western University Canada

Conditions & Keywords Data

Conditions:
Name
Crohn Disease
Inflammatory Bowel Diseases
Ulcerative Colitis
Keywords:
Name View
Pharmacogenomics View
Combination therapy View
Infliximab View